DAX

DGAP-News: ENCAVIS AG improves ISS ESG rating

Ethical investment, Environmentalism, Ethical banking, Governance, Articles, Finance, Money, Environmental, social and corporate governance, ESG, DAX, RepRisk
Thursday, January 14, 2021 - 6:03am

Hamburg, January 14, 2021 - The SDAX-listed wind and solar park operator Encavis AG (ISIN: DE0006095003, Prime Standard, ticker symbol: ECV) was able to further improve its rating from the renowned rating agency ISS ESG within the Prime status.

Key Points: 
  • Hamburg, January 14, 2021 - The SDAX-listed wind and solar park operator Encavis AG (ISIN: DE0006095003, Prime Standard, ticker symbol: ECV) was able to further improve its rating from the renowned rating agency ISS ESG within the Prime status.
  • The ISS ESG rating evaluates the sustainability performance of companies and has a best-in-class approach, in which also industry-specific rating criteria are - with approximately one third - included in the evaluation.
  • Encavis AG (Prime Standard; ISIN: DE0006095003 / WKN: 609500) is a producer of electricity from renewable energies listed on the SDAX of Deutsche Brse AG.
  • Encavis AG's environmental, social and governance performance has been awarded an "A" level by two of the world's leading ESG research and rating agencies MSCI ESG Ratings as well as a "Prime" corporate ESG performance by ISS ESG.

DGAP-News: MorphoSys To Present At the 39th Annual J.P. Morgan Healthcare Conference

MorphoSys, TecDAX, Financial markets, Finance, MDAX, Prime Standard, CDAX, DAX, J. P. Morgan, Industry economics)
Monday, January 11, 2021 - 12:10pm

MorphoSys To Present At the 39th Annual J.P. Morgan Healthcare Conference

Key Points: 
  • MorphoSys To Present At the 39th Annual J.P. Morgan Healthcare Conference
    The issuer is solely responsible for the content of this announcement.
  • MorphoSys To Present At the 39th Annual J.P. Morgan Healthcare Conference
    MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR), a commercial-stage biopharmaceutical company and a leader in antibody, protein and peptide technologies, announced today that Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys, will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday January 13 at 2:50 p.m. EST.
  • Live audio of the presentation can be accessed from the Media and Investors section under Conferences on MorphoSys' website, www.morphosys.com .
  • Headquartered near Munich, Germany, the MorphoSys group, including the fully owned U.S. subsidiary MorphoSys US Inc., has more than 600 employees.

DGAP-News: ENCAVIS AG starts into 2021 with its new Stock Exchange Initial 'ECV'

Prime Standard, Stock market, SDAX, DAX, Stock exchange
Monday, January 4, 2021 - 6:01am

Hamburg, January 4, 2021 - SDAX-listed wind and solar park operator Encavis AG (Prime Standard, ISIN: DE0006095003, Stock Exchange Initial: ECV), will be listed from now on with its the new Stock Exchange Initial ECV - corresponding to its Company name (hitherto CAP according to its former Company name Capital Stage).

Key Points: 
  • Hamburg, January 4, 2021 - SDAX-listed wind and solar park operator Encavis AG (Prime Standard, ISIN: DE0006095003, Stock Exchange Initial: ECV), will be listed from now on with its the new Stock Exchange Initial ECV - corresponding to its Company name (hitherto CAP according to its former Company name Capital Stage).
  • "We are pleased to mirror our Company name ENCAVIS in our current Stock exchange initial ECV: Representing our Vision to combine smart financing with investments in sustainable and profitable production and marketing of Renewable Energy", Dr Christoph Husmann, CFO of Encavis AG, underlined the future identity of Corporate purpose, Company name and Stock Exchange Initial of the Group.
  • ENCAVIS AG (Prime Standard; ISIN: DE0006095003; Stock Exchange Initial: ECV) is a producer of electricity from renewable energies listed on the SDAX of Deutsche Brse AG.
  • Within the ENCAVIS Group, Encavis Asset Management AG specializes in the institutional investor segment.

DGAP-News: home24 SE: home24 confirms strong November trading, moves up into the German SDAX index and prepares for a potential IPO of its Brazilian business

SDAX, DAX
Friday, December 4, 2020 - 5:01pm

home24 SE: home24 confirms strong November trading, moves up into the German SDAX index and prepares for a potential IPO of its Brazilian business

Key Points: 
  • home24 SE: home24 confirms strong November trading, moves up into the German SDAX index and prepares for a potential IPO of its Brazilian business
    The issuer is solely responsible for the content of this announcement.
  • Mobly S.A., home24's Brazilian subsidiary, today is filing preliminary documentation for a potential listing in Brazil in 2021.
  • As of 21st of December 2020, home24 will be listed in the SDAX index by Deutsche Brse.
  • We are grateful that our efforts are starting to pay off and have led to the inclusion to the German SDAX index.

DGAP-News: HENSOLDT AG to enter SDAX

Hensoldt, SDAX, DAX, Economy of Germany, Germany
Friday, December 4, 2020 - 1:12pm

Taufkirchen, December 4, 2020 - HENSOLDT AG ("HENSOLDT") will be listed in the SDAX, the Small-Cap-Index of the Frankfurt Stock Exchange, starting at December 21, 2020 according to an announcement made by Deutsche Brse yesterday evening.

Key Points: 
  • Taufkirchen, December 4, 2020 - HENSOLDT AG ("HENSOLDT") will be listed in the SDAX, the Small-Cap-Index of the Frankfurt Stock Exchange, starting at December 21, 2020 according to an announcement made by Deutsche Brse yesterday evening.
  • Thomas Mlller, CEO of HENSOLDT AG, said: "We are very excited to join the SDAX family only a few months after our IPO on the Frankfurt Stock Exchange.
  • HENSOLDT develops new products to combat a wide range of threats based on innovative approaches to data management, robotics and cyber security.
  • With more than 5,500 employees, HENSOLDT generated revenue of EUR 1.11 billion in 2019.

DGAP-News: Wüstenrot & Württembergische AG no longer in the SDAX

Stock exchange, Dividend, Investment, DAX, Economies, Economy of Europe
Friday, December 4, 2020 - 8:01am

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • The stock of Wstenrot & Wrttembergische AG (W&W) will no longer be listed in the SDAX index of the Frankfurt stock exchange from 21 December 2020.
  • The reason for this is the relatively low trading volume in free float, which is a key criterion for membership of the SDAX.
  • With its stable and reliable dividend and its attractive price potential, the W&W stock thus remains a sustainable and profitable investment, in particular for investors focussing on long-term value.

DGAP-News: flatexDEGIRO AG to be included in the SDAX

SDAX, DAX
Friday, December 4, 2020 - 7:00am

Frankfurt/Main - flatexDEGIRO AG (WKN: FTG111, ISIN: DE000FTG1111, Ticker: FTK.GR), Europe's largest retail online broker, will be included in the SDAX.

Key Points: 
  • Frankfurt/Main - flatexDEGIRO AG (WKN: FTG111, ISIN: DE000FTG1111, Ticker: FTK.GR), Europe's largest retail online broker, will be included in the SDAX.
  • As Deutsche Brse announced yesterday, the SDAX listing of flatexDEGIRO AG will take effect on 21 December 2020.
  • The SDAX listing makes flatexDEGIRO one of the 160 largest listed companies in Germany.
  • Our listing in the SDAX and the resulting growing visibility will enable investors worldwide to participate even better in our operational success," says Muhamad Said Chahrour, CFO of flatexDEGIRO AG.

DGAP-News: EVOTEC PRESENTS GROWTH DRIVERS OF 'AUTOBAHN TO CURES' AT CAPITAL MARKETS DAY

Evotec, TecDAX, MDAX, CDAX, DAX, Stock exchange, Industries, Economies, Economy of Europe
Thursday, November 19, 2020 - 7:04am

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today presents the progress made in accelerating its co-owned pipeline and its global infrastructure "The R&D Autobahn to Cures".

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today presents the progress made in accelerating its co-owned pipeline and its global infrastructure "The R&D Autobahn to Cures".
  • The Company is hosting a virtual Capital Markets Day for investors and interested stakeholders.
  • Evotec will host its virtual Capital Markets Day on 19 November 2020, starting at 8.30 am EST (2.30 pm CET, 1.30 pm GMT).
  • The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release.

Nuance and Providence Collaborate to Create a Better Patient Experience and Ease Clinician Burden

Nuance Communications, Speaker recognition, Nuance, DAX
Thursday, November 12, 2020 - 2:00pm

Together, Providence and Nuance will also develop integrated clinical intelligence and enhanced revenue cycle solutions.

Key Points: 
  • Together, Providence and Nuance will also develop integrated clinical intelligence and enhanced revenue cycle solutions.
  • To further improve healthcare experiences for both providers and patients, Providence will build on its deployment of Nuance Dragon Medical One with the Dragon Ambient eXperience (DAX).
  • As part of the expanded partnership, Nuance and Providence will jointly innovate to create technologies that improve health system efficiency by reducing digital friction.
  • Trademark reference: Nuance and the Nuance logo are registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates inthe United Statesand/or other countries.

DGAP-News: EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2020 ON 12 NOVEMBER 2020

Evotec, TecDAX, CDAX, MDAX, DAX, Industries, Presentation slide, Slide, Webcast, Telecommunications, Multimedia
Thursday, November 5, 2020 - 1:12pm

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will announce its financial results for the first nine months of 2020 on Thursday, 12 November 2020.

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will announce its financial results for the first nine months of 2020 on Thursday, 12 November 2020.
  • The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance.
  • Time: 02.00 pm CET (08.00 am EST, 01.00 pm GMT)
    A simultaneous slide presentation for participants dialling in via phone is available at https://www.webcast-eqs.com/evotec20201112/no-audio.
  • To join the audio webcast and to access the presentation slides you will find a link on our homepage www.evotec.com shortly before the event.